Journal of Affective Disorders

The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder.  315:13-16. 2022

Adverse childhood experiences and adolescent mental health: Understanding the roles of gender and teenage risk and protective factors.  314:303-308. 2022

Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response.  300:41-49. 2022

Melanopsin-driven pupil response in summer and winter in unipolar seasonal affective disorder.  291:93-101. 2021

Examining the temporal stability of suicide capability among undergraduates: A latent growth analysis.  282:587-593. 2021

Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: Analysis of the CLARITY study.  277:478-485. 2020

Development of a patient decision aid for treatment resistant depression.  275:299-306. 2020

Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response.  273:131-137. 2020

Parenting stress and family resilience affect the association of adverse childhood experiences with children's mental health and attention-deficit/hyperactivity disorder.  272:104-109. 2020

The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study.  266:772-781. 2020

Elevated expression of unfolded protein response genes in the prefrontal cortex of depressed subjects: Effect of suicide.  262:229-236. 2020

Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship.  259:164-172. 2019

Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors.  257:17-22. 2019

Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale.  246:126-131. 2019

GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort.  243:16-22. 2019

MicroRNAs in depression and suicide: Recent insights and future perspectives.  240:146-154. 2018

Determining the optimal clinical cutoff on the CES-D for depression in a community corrections sample.  234:270-275. 2018

Corrigendum to bipolar mixed features – Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183–189], (S0165032716323047), (10.1016/j.jad.2017.03.070)).  225:775-777. 2018

Interaction between early-life stress and FKBP5 gene variants in major depressive disorder and post-traumatic stress disorder: A systematic review and meta-analysis.  225:422-428. 2018

Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial.  225:563-568. 2018

Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder.  223:146-152. 2017

Bipolar mixed features – Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study.  217:183-189. 2017

Clinical correlates of acute bipolar depressive episode with psychosis.  217:29-33. 2017

Deconstructing Bipolar Disorder and Schizophrenia: A cross-diagnostic cluster analysis of cognitive phenotypes.  209:71-79. 2017

Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study.  205:159-164. 2016

A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report.  192:212-218. 2016

The role of sex, gender, and education on depressive symptoms among young adults in the United States.  189:306-313. 2016

Generalized Anxiety Disorder in racial and ethnic minorities: A case of nativity and contextual factors.  175:275-280. 2015

Panic attacks in minority Americans: The effects of alcohol abuse, tobacco smoking, and discrimination.  174:106-112. 2015

Erratum: "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar i or II disorder: Results from the bipolar CHOICE trial" [Journal of Affective Disorders (2014) 161 (30-35)].  167:259-260. 2014

Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar i or II disorder: Results from the Bipolar CHOICE trial.  161:30-35. 2014

Alteration of cyclic-AMP response element binding protein in the postmortem brain of subjects with bipolar disorder and schizophrenia.  152-154:326-333. 2014

Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder.  151:722-727. 2013

Cooperation and depressive symptoms.  150:1184-1187. 2013

Killing and latent classes of PTSD symptoms in Iraq and Afghanistan veterans.  145:344-348. 2013

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report.  133:467-476. 2011

Prevalence and correlates of eating disorders in 875 patients with bipolar disorder.  128:191-198. 2011

Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.  126:420-429. 2010

Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder.  126:303-311. 2010

Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy.  110:161-166. 2008

Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features.  87:43-55. 2005

Divalproex in the treatment of bipolar depression: A placebo-controlled study.  85:259-266. 2005

Do venlafaxine XR and paroxetine equally influence negative and positive affect?.  85:333-339. 2005

Assessing the effects of bupropion SR on mood dimensions of depression.  78:235-241. 2004

Cross-talk between PKA and PKC in human fibroblasts: What are the pharmacotherapeutic implications?.  65:275-279. 2001

Human fibroblasts as a relevant model to study signal transduction in affective disorders.  61:51-58. 2000